Search results
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Author(s):
Mathew S Maurer
,
Margot K Davis
Added:
3 weeks ago
Video Series
Author(s):
Athena Adeli
,
Revathy Sampath-Kumar
,
Anne Wang
,
et al
Added:
2 weeks ago
Benefits of Spironolactone: Win Ratio Analysis of the TOPCAT Trial
Author(s):
Dung Viet Nguyen
,
Hoai Thi Thu Nguyen
Added:
7 months ago
Original Research
Author(s):
Akshay S Desai
Added:
1 year ago
HFSA 24 - Dr Akshay Desai (Brigham and Women’s Hospital, US) sits down with us to discuss the findings from FINEARTS-HF across the ejection fraction spectrum in heart failure with mildly reduced and preserved ejection fraction.Interview Questions:1. What was the reasoning behind this study? What was the study design and patient population?2. What was the study design and patient population?3…
View more
Reverse Remodelling in HFrEF
Author(s):
Silas Ramos Furquim
,
Maria Tereza Sampaio de Sousa Lira
,
Deborah de Sá Pereira Belfort
,
et al
Added:
6 months ago
Review Article
ARNI for Optimising HFrEF Management
Author(s):
Massimo Iacoviello
,
Filippo M Sarullo
,
Claudio Bilato
,
et al
Added:
10 months ago
Expert Opinion
Added:
8 months ago
Source:
Radcliffe Cardiology
AUTHOR: Yazmin SadikNew findings from the DIGIT-HF trial indicate that adding low-dose digitoxin to guideline-directed medical therapy (GDMT) can reduce the risk of hospitalisation and all-cause mortality in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).¹The results were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously…
View more
Author(s):
Lin Yee Chen
Added:
4 hours ago
Dr Lin Yee Chen (University of Minnesota Medical School, Minneapolis, MN, US) joins us to examine which artificial intelligence (AI) applications in heart failure are ready for clinical use today, and which remain experimental. As AI moves from research settings into the clinic, separating genuine clinical utility from hype has become a pressing question for heart failure specialists.In this…
View more
Author(s):
Milton Packer
Added:
1 week ago
Dr Milton Packer (Baylor University Medical Center, Dallas, TX, US) joins us for a wide-ranging discussion on the conceptual foundations of heart failure, challenging several long-held assumptions about its mechanisms, classification and therapeutic targets, and considering what the field may still be getting wrong.In this interview, Dr Packer sets out why he believes some core ideas in heart…
View more
Author(s):
Victoria Delgado
,
Philippe Debonnaire
Added:
2 weeks ago
Heart Failure Association Congress 2026 — Dr Philippe Debonnaire (AZ Sint Jan, Brugge, BE) and Professor Victoria Delgado (University Hospital Germans Trias i Pujol, Badalona, SP) discuss the expanding role of advanced cardiac imaging in heart failure diagnosis and management, and what a more personalised, multimodality approach means for clinical practice.The conversation moves beyond…
View more
